Skip to NavigationSkip to content


Sanofi invests €66m in Chinese R&D hub

French multinational Sanofi is investing €66 million in a tech-focused operation in China in an effort to increase efficiency and speed up the analysis of clinical trials. The French pharmaceutical company’s new hub will be based in the rapidly developing city of Chengdu in the centrally located Sichuan province.

Mission Statement is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches